Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) reached a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 26.40 ($0.34) and last traded at GBX 27.35 ($0.36), with a volume of 15301 shares trading hands. The stock had previously closed at GBX 28 ($0.36).
Cambridge Cognition Stock Performance
The company has a quick ratio of 0.96, a current ratio of 0.65 and a debt-to-equity ratio of 92.53. The stock’s 50 day moving average price is GBX 37.76 and its 200-day moving average price is GBX 42.16. The stock has a market capitalization of £11.74 million, a P/E ratio of -700.00 and a beta of 0.72.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- The Basics of Support and Resistance
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Are the FAANG Stocks and Are They Good Investments?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What Are the U.K. Market Holidays? How to Invest and Trade
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.